MEGIN Masterclass

MEG in Pharmaco Symposium 2024, Geneva

Presented by MEGIN and Krish Singh, PhD at Campus Biotech, Geneva.

Abstract: Showcasing how MEG can be used in drug discovery and evaluation work & could support in drug development trials.* Hosted by MEGIN and Krish Singh, PhD at Campus Biotech, Geneva.

00:00:26 – Opening remarks by H.E. Ms. Heidi Schroderus-Fox, Ambassador, Permanent Representative of Finland to the UN and international organizations in Geneva and Professor Krish Singh, PhD

00:06:26 – Krish Singh, PhD: MEG-derived non-invasive markers of oscillatory activity and connectivity in human drug target engagement studies

Professor, Head of Human Electrophysiology, Cardiff University Brain Research Imaging Centre (CUBRIC)

00:42:10 – Neil Harrison, PhD MRCP MRC Psych: The crisis in psychiatry drug discovery: can in-vivo target engagement measures save us?

Clinical Professor in Neuroimaging, Cardiff University Brain Research Imaging Centre (CUBRIC)

01:06:03 – Emily Rogers, PhD: MEG Beyond Academia: How Can We Best Leverage and Expand MEG To Address Unmet Needs in Industry, Medical Science Liaison, Neuralis

01:31:45 – Christos Papadelis, PhD: Electrophysiological Biomarkers of GABA in Children with Dravet Syndrome

Director of Neuroscience Research, Cook Children’s Health Care, Professor of Pediatrics, Texas Christian University School of Medicine

01:56:32 – Hanna Renvall, PhD: Time-resolved tracking of neuronal activity combined with artificial intelligence: Tools for predicting dementia risk

Head of the MEG Lab at BioMag Laboratory at Helsinki University Hospital

Assistant Professor in Translational Neuroimaging, Aalto University and Helsinki University Hospital

02:22:17 – Laura Hughes, PhD: MEG: Sensitivity to pharmaco modulation in health and in dementia

Postdoctoral Fellow, MRC Cognition and Brain Sciences Unit, University of Cambridge

02:48:42 – Srikantan Nagarajan, PhD: Neurophysiological network alterations and trajectories in dementia

Professor, Director of Neuroimaging, Director, Biomagnetic Imaging Lab, UCSF

03:26:11 – Elizabeth Davenport, PhD: Tau Delta: The Unlikely Fraternity of Pediatric Football Players and Alzheimer’s Patients

Assistant Professor of Radiology

Technical Director for the Magnetoencephalography Center of UT Southwestern Medical Center

03:52:15 – Giulio Pergola, PhD: All roads lead to Schizophrenia: parsing risk into biological pathways

Associate Professor of Cognitive Neuroscience and Biological Psychology, Scientific Director – Group of Psychiatric Neuroscience, University of Bari Aldo Moro
Investigator, Lieber Institute for Brain Development
Associate Professor of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine

04:20:06 – James Rowe, PhD, MD: MEG markers of Alzheimer’s disease, severity and progression

Professor of Cognitive Neurology, University of Cambridge

04:50:39 – Olivier Reynaud, Campus Biotech MEG lab

04:56:29 – Alexis Hervais-Adelman, NCCR Evolving language

05:06:29 – Closing remarks from MEGIN

*The MEGIN Masterclasses content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned.

**TRIUX™ neo is intended to non-invasively record brain activity, and when interpreted by trained physicians, to help localize these active areas. All other applications are scientific research in nature. Please contact MEGIN for further information.